Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly ...

Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...

Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis ... least two radiological features suggestive of fibrosis † without presence ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...

She shared how much healthier she's become after making 'simple' change to her diet by adding one supplement to her daily ...

Meanwhile, in the UK alone there are over 10,000 people living with cystic fibrosis (CF). Despite significant advances in treatment in recent years, those living with the condition on average ...

Albany Medical Center’s adult Cystic Fibrosis Care Center has been treating patients aged 18 and older living with cystic fibrosis (CF).